PeruForeign medical devices manufacturers entering Peru must appoint a qualified local Legal Representative recognized by DIGEMID before any product can be registered or sold. Taevas Global provides end-to-end Legal Representation services so your devices rea
Our Legal Representation service for Peru is built on six interconnected pillars that cover every regulatory, commercial, and operational dimension a medical devices company needs to enter and grow in this market.
We act as your appointed Legal Representative before DIGEMID, ensuring all medical device registrations comply with Decreto Supremo N 016-2011-SA and subsequent amendments. Our team monitors regulatory updates and ensures your portfolio remains continuously compliant throughout its lifecycle in Peru.
Our four-step engagement model takes you from initial scoping to fully established Legal Representation in Peru, with clear milestones and transparent communication at every stage.
We begin with a structured intake session to understand your device portfolio, target indications, existing regulatory approvals (FDA, CE, or equivalent), and commercial timeline for Peru. This scoping call defines the scope of Legal Representation, identifies which devices require full registration versus simplified pathways, and establishes a project plan.
During intake we review your existing technical files, ISO 13485 certificates, and any prior DIGEMID correspondence. We map each device to the Peruvian classification system and flag any documentation gaps that must be resolved before submission. You receive a written scoping report with timelines, fees, and a risk register within 72 hours of the intake call.
Peru imports the vast majority of its medical devices, with the United States, Germany, China, and Brazil among the leading source countries. Local manufacturing capacity is limited primarily to lower-risk consumables, meaning foreign manufacturers face strong structural demand across virtually all device categories. This import dependency makes a compliant Legal Representative essential for any brand seeking shelf presence.
DIGEMID has been actively modernizing its medical device regulatory framework, introducing electronic submission pathways and aligning classification criteria more closely with PAHO and GHTF global standards. Manufacturers holding CE marks or FDA clearances can leverage these equivalence provisions to accelerate registration timelines under simplified pathways. Staying current with DIGEMID regulatory updates is critical to avoiding rework.
EsSalud (the national social health insurer) and MINSA together account for a dominant share of medical device procurement in Peru, particularly for capital equipment, imaging, and in-vitro diagnostics. Inclusion on official petitorios and participation in SEACE tenders are therefore strategic imperatives for manufacturers targeting meaningful volume. Private clinic chains in Lima are growing but remain secondary in overall spend.
Peru's post-pandemic health system investment has accelerated demand for diagnostic equipment, point-of-care testing devices, and digital health infrastructure. The government's push to expand laboratory capacity in regional hospitals outside Lima is creating new procurement opportunities for IVD and imaging device manufacturers. Companies that establish early Legal Representation and registration are best positioned to capture these institutional contracts.
Every Taevas Global Legal Representation engagement for Peru includes a defined set of deliverables designed to give medical devices companies complete regulatory coverage and commercial readiness from day one.
Formal appointment of Taevas Global as your official Legal Representative before DIGEMID, including preparation and notarization of the poder notarial and registration of the appointment in DIGEMID's records.
A written report mapping each device in your portfolio to the applicable DIGEMID registration pathway, risk class, and estimated timeline, with a gap analysis identifying any missing documentation.
Full preparation of the DIGEMID-format technical dossier in Spanish, including labeling adaptation, instructions for use translation, and clinical evidence summary for each device submitted.
End-to-end management of the DIGEMID submission process, including filing, fee payment coordination, and a live case tracker updated weekly so your team always knows current status.
Establishment of a local adverse event reporting point of contact, template incident report forms aligned with DIGEMID requirements, and a documented vigilance procedure for your Peru operations.
Support for import permit applications, customs documentation review, and coordination with your appointed Peruvian distributor to ensure shipments clear customs without regulatory holds.
Quarterly regulatory update briefings covering new DIGEMID resolutions, classification changes, and labeling requirements that affect your registered portfolio, delivered as plain-language summaries.
Proactive tracking of Registro Sanitario expiry dates with renewal reminders issued 12 months in advance, plus full management of the renewal dossier preparation and submission on your behalf.
Your company has CE marking or FDA clearance and is ready to expand into Latin America, with Peru identified as a priority market. You have no existing local entity, no DIGEMID registrations, and need a trusted Legal Representative who can handle the full regulatory process while you focus on commercial planning. Speed and accuracy in the registration phase are critical to your regional rollout timeline.
Taevas Global provides Medical Devices manufacturers with a fully managed Legal Representation service in Peru, from DIGEMID appointment through registration, post-market surveillance, and beyond. Contact us today to discuss your portfolio and get a tailored proposal.